{"product_id":"stem-cell-therapy-owner-makes","title":"How Much Can a Stem Cell Therapy Clinic Owner Make? $151K\/Month","description":"\u003cbr\u003e\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"line_top\"\u003e\u003c\/div\u003e\n\u003cp\u003eYou’re planning a high-ticket medical clinic, so owner income can look large on paper but still depends on volume, staffing, compliance, and cash kept in the business In the researched first-year case, the clinic produces \u003cstrong\u003e$314,325 in monthly revenue\u003c\/strong\u003e and about \u003cstrong\u003e$151,152 in monthly operating profit before taxes, debt service, and reserves\u003c\/strong\u003e This covers revenue, gross margin, operating costs, owner compensation logic, and scenario planning it does not cover personal tax advice, medical claims, or guaranteed outcomes\u003c\/p\u003e\n\n\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\" id=\"main_article_image\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003csection class=\"fml-owner-metric-cards\" aria-label=\"Stem Cell Therapy Clinic KPI cards\"\u003e\u003cdiv class=\"metric-grid\"\u003e\n\u003carticle class=\"metric-card is-green\"\u003e\u003cspan class=\"metric-icon-tip\" tabindex=\"0\" data-tooltip=\"First-year operating profit before taxes, debt, and reserves; it is not owner salary, so actual cash can be lower.\"\u003e\u003cimg class=\"metric-icon\" src=\"\/cdn\/shop\/files\/fml-owner-income-kpi-owner-income.svg\" alt=\"Owner income icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003eOwner income\u003c\/span\u003e\u003cstrong class=\"metric-value\" tabindex=\"0\" data-tooltip=\"First-year operating profit before taxes, debt, and reserves; it is not owner salary, so actual cash can be lower.\"\u003e$151k\u003c\/strong\u003e\u003c\/article\u003e\u003carticle class=\"metric-card\"\u003e\u003cspan class=\"metric-icon-tip\" tabindex=\"0\" data-tooltip=\"First-year contribution margin from treatment revenue after kits, lab fees, and variable clinic costs; it excludes payroll, rent, marketing, malpractice, and compliance.\"\u003e\u003cimg class=\"metric-icon\" src=\"\/cdn\/shop\/files\/fml-owner-income-kpi-net-margin.svg\" alt=\"Net margin icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003eNet margin\u003c\/span\u003e\u003cstrong class=\"metric-value\" tabindex=\"0\" data-tooltip=\"First-year contribution margin from treatment revenue after kits, lab fees, and variable clinic costs; it excludes payroll, rent, marketing, malpractice, and compliance.\"\u003e77.5%\u003c\/strong\u003e\u003c\/article\u003e\u003carticle class=\"metric-card\"\u003e\u003cspan class=\"metric-icon-tip\" tabindex=\"0\" data-tooltip=\"First-year run rate from $314,325 monthly revenue; collected price and treatment capacity drive it, and collections can still lag.\"\u003e\u003cimg class=\"metric-icon\" src=\"\/cdn\/shop\/files\/fml-owner-income-kpi-revenue-target.svg\" alt=\"Revenue for target pay icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003eRevenue for target pay\u003c\/span\u003e\u003cstrong class=\"metric-value\" tabindex=\"0\" data-tooltip=\"First-year run rate from $314,325 monthly revenue; collected price and treatment capacity drive it, and collections can still lag.\"\u003e$3.77M\u003c\/strong\u003e\u003c\/article\u003e\u003carticle class=\"metric-card\"\u003e\u003cspan class=\"metric-icon-tip\" tabindex=\"0\" data-tooltip=\"High capex, staffing, malpractice, and compliance make execution tough even with strong modeled returns and fast payback.\"\u003e\u003cimg class=\"metric-icon\" src=\"\/cdn\/shop\/files\/fml-owner-income-kpi-business-difficulty.svg\" alt=\"Business difficulty icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003eBusiness difficulty\u003c\/span\u003e\u003cstrong class=\"metric-value\" tabindex=\"0\" data-tooltip=\"High capex, staffing, malpractice, and compliance make execution tough even with strong modeled returns and fast payback.\"\u003eHard\u003c\/strong\u003e\u003c\/article\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWant to test your clinic owner income?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003csection class=\"fml-owner-calculator\" aria-label=\"Stem Cell Therapy Clinic Owner Income Calculator\" data-locale=\"en-US\" data-currency=\"USD\" data-default-scenario=\"base\" data-export-filename=\"Stem Cell Therapy Clinic Owner Income Calculator.xlsx\" data-source-site-name=\"Financial Models Lab\" data-source-site-url=\"https:\/\/financialmodelslab.com\" data-source-page-title=\"Stem Cell Therapy Clinic Owner Income Calculator\" data-note-title=\"Planning note:\" data-note-text=\"Research-based planning estimate only. It is not guaranteed salary, tax advice, or owner distribution advice.\"\u003e\u003cdiv class=\"fml-owner-card\"\u003e\n\u003cheader class=\"fml-owner-header\"\u003e\u003cdiv class=\"fml-owner-heading\"\u003e\n\u003cp class=\"fml-owner-eyebrow\"\u003eOwner income calculator\u003c\/p\u003e\n\u003cp class=\"fml-owner-intro\"\u003eEstimate owner take-home and target-pay gap from revenue, margin, costs, reserves, and target pay.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-scenarios\" aria-label=\"Income scenario presets\"\u003e\n\u003cbutton class=\"fml-owner-scenario\" type=\"button\" data-scenario=\"low\"\u003eLow\u003c\/button\u003e\u003cbutton class=\"fml-owner-scenario is-active\" type=\"button\" data-scenario=\"base\"\u003eBase\u003c\/button\u003e\u003cbutton class=\"fml-owner-scenario\" type=\"button\" data-scenario=\"high\"\u003eHigh\u003c\/button\u003e\n\u003c\/div\u003e\u003c\/header\u003e\u003cdiv class=\"fml-owner-layout\"\u003e\n\u003cform class=\"fml-owner-inputs\"\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eMonthly revenue\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly collected sales before expenses. Use the average operating month, not a one-time peak month.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly collected sales before expenses. Use the average operating month, not a one-time peak month.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-money\"\u003e\n\u003cspan\u003e$\u003c\/span\u003e\u003cinput data-owner-field=\"monthlyRevenue\" data-owner-kind=\"money\" data-owner-label=\"Monthly revenue\" data-owner-note=\"Monthly collected sales before expenses. Use the average operating month, not a one-time peak month.\" data-low=\"314333\" data-base=\"1071833\" data-high=\"2146917\" name=\"monthlyRevenue\" type=\"text\" inputmode=\"numeric\" value=\"1,071,833\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eGross margin\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Percent of revenue left after direct treatment costs like biologic kits and lab processing.\"\u003ei\u003cspan role=\"tooltip\"\u003ePercent of revenue left after direct treatment costs like biologic kits and lab processing.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-percent\"\u003e\n\u003cinput data-owner-field=\"grossMargin\" data-owner-kind=\"percent\" data-owner-label=\"Gross margin\" data-owner-note=\"Percent of revenue left after direct treatment costs like biologic kits and lab processing.\" name=\"grossMargin\" type=\"range\" min=\"0\" max=\"100\" step=\"1\" data-low=\"83\" data-base=\"85\" data-high=\"87\" value=\"85\"\u003e\u003coutput\u003e85%\u003c\/output\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eLabor cost\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly payroll and staffing coverage before owner pay.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly payroll and staffing coverage before owner pay.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-money\"\u003e\n\u003cspan\u003e$\u003c\/span\u003e\u003cinput data-owner-field=\"laborCost\" data-owner-kind=\"money\" data-owner-label=\"Labor cost\" data-owner-note=\"Monthly payroll and staffing coverage before owner pay.\" data-low=\"64750\" data-base=\"94917\" data-high=\"125083\" name=\"laborCost\" type=\"text\" inputmode=\"numeric\" value=\"94,917\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eFixed overhead\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Rent, insurance, software, utilities, admin, and compliance costs that stay on each month.\"\u003ei\u003cspan role=\"tooltip\"\u003eRent, insurance, software, utilities, admin, and compliance costs that stay on each month.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-money\"\u003e\n\u003cspan\u003e$\u003c\/span\u003e\u003cinput data-owner-field=\"fixedOverhead\" data-owner-kind=\"money\" data-owner-label=\"Fixed overhead\" data-owner-note=\"Rent, insurance, software, utilities, admin, and compliance costs that stay on each month.\" data-low=\"27700\" data-base=\"27700\" data-high=\"27700\" name=\"fixedOverhead\" type=\"text\" inputmode=\"numeric\" value=\"27,700\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eMarketing\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly patient acquisition spend needed to keep demand moving.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly patient acquisition spend needed to keep demand moving.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-money\"\u003e\n\u003cspan\u003e$\u003c\/span\u003e\u003cinput data-owner-field=\"marketing\" data-owner-kind=\"money\" data-owner-label=\"Marketing\" data-owner-note=\"Monthly patient acquisition spend needed to keep demand moving.\" data-low=\"18860\" data-base=\"53592\" data-high=\"85877\" name=\"marketing\" type=\"text\" inputmode=\"numeric\" value=\"53,592\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eDebt service\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly loan or financing payment tied to the clinic model.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly loan or financing payment tied to the clinic model.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-money\"\u003e\n\u003cspan\u003e$\u003c\/span\u003e\u003cinput data-owner-field=\"debtService\" data-owner-kind=\"money\" data-owner-label=\"Debt service\" data-owner-note=\"Monthly loan or financing payment tied to the clinic model.\" data-low=\"0\" data-base=\"0\" data-high=\"0\" name=\"debtService\" type=\"text\" inputmode=\"numeric\" value=\"\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eTax reserve\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Percent of profit held back for taxes before owner take-home.\"\u003ei\u003cspan role=\"tooltip\"\u003ePercent of profit held back for taxes before owner take-home.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-percent\"\u003e\n\u003cinput data-owner-field=\"taxReserve\" data-owner-kind=\"percent\" data-owner-label=\"Tax reserve\" data-owner-note=\"Percent of profit held back for taxes before owner take-home.\" name=\"taxReserve\" type=\"range\" min=\"0\" max=\"45\" step=\"1\" data-low=\"18\" data-base=\"24\" data-high=\"28\" value=\"24\"\u003e\u003coutput\u003e24%\u003c\/output\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eReinvestment reserve\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Percent of profit kept for growth, repairs, working capital, and risk buffer.\"\u003ei\u003cspan role=\"tooltip\"\u003ePercent of profit kept for growth, repairs, working capital, and risk buffer.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-percent\"\u003e\n\u003cinput data-owner-field=\"reinvestmentReserve\" data-owner-kind=\"percent\" data-owner-label=\"Reinvestment reserve\" data-owner-note=\"Percent of profit kept for growth, repairs, working capital, and risk buffer.\" name=\"reinvestmentReserve\" type=\"range\" min=\"0\" max=\"35\" step=\"1\" data-low=\"5\" data-base=\"10\" data-high=\"14\" value=\"10\"\u003e\u003coutput\u003e10%\u003c\/output\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eTarget owner pay\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly owner income target used to measure the gap against modeled take-home.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly owner income target used to measure the gap against modeled take-home.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-money\"\u003e\n\u003cspan\u003e$\u003c\/span\u003e\u003cinput data-owner-field=\"targetOwnerPay\" data-owner-kind=\"money\" data-owner-label=\"Target owner pay\" data-owner-note=\"Monthly owner income target used to measure the gap against modeled take-home.\" data-low=\"75000\" data-base=\"150000\" data-high=\"250000\" name=\"targetOwnerPay\" type=\"text\" inputmode=\"numeric\" value=\"150,000\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/form\u003e\n\u003caside class=\"fml-owner-results\" aria-live=\"polite\"\u003e\u003cspan class=\"fml-owner-tag\"\u003eOwner income output\u003c\/span\u003e\u003cdiv class=\"fml-owner-metrics\"\u003e\n\u003cdiv class=\"fml-owner-metric is-primary\"\u003e\n\u003cspan class=\"fml-owner-metric-label\"\u003eOwner Income\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly take-home after tax and reinvestment reserves.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly take-home after tax and reinvestment reserves.\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cstrong data-owner-output=\"monthlyOwnerIncome\"\u003e$485K\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-metric\"\u003e\n\u003cspan class=\"fml-owner-metric-label\"\u003eNet Margin\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Owner income divided by monthly revenue.\"\u003ei\u003cspan role=\"tooltip\"\u003eOwner income divided by monthly revenue.\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cstrong data-owner-output=\"netProfitMargin\"\u003e45%\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-metric\"\u003e\n\u003cspan class=\"fml-owner-metric-label\"\u003eRevenue for Target Pay\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly revenue needed to support the target owner pay.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly revenue needed to support the target owner pay.\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cstrong data-owner-output=\"revenueNeeded\"\u003e$475K\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-metric is-target-gap is-positive\"\u003e\n\u003cspan class=\"fml-owner-metric-label\"\u003eTarget Pay Gap\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Owner income minus target owner pay. Negative means the target pay is not covered.\"\u003ei\u003cspan role=\"tooltip\"\u003eOwner income minus target owner pay. Negative means the target pay is not covered.\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cstrong data-owner-output=\"targetPayGap\"\u003e$335K\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdl class=\"fml-owner-result-list\"\u003e\n\u003cdiv\u003e\n\u003cdt\u003eAnnual owner income\u003c\/dt\u003e\n\u003cdd data-owner-output=\"annualOwnerIncome\"\u003e$5,820,001\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdt\u003eProfit before reserves\u003c\/dt\u003e\n\u003cdd data-owner-output=\"profitBeforeReserves\"\u003e$734,849\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdt\u003eTax + reinvestment reserve\u003c\/dt\u003e\n\u003cdd data-owner-output=\"reserveAmount\"\u003e$249,849\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdt\u003eTarget pay gap\u003c\/dt\u003e\n\u003cdd data-owner-output=\"cashAfterTargetPay\"\u003e$335,000\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003c\/dl\u003e\n\u003cdiv class=\"fml-owner-bridge\"\u003e\n\u003cdiv class=\"fml-owner-bar-row\" data-owner-bridge=\"revenue\"\u003e\n\u003cspan\u003eRevenue\u003c\/span\u003e\u003cdiv\u003e\u003ci style=\"--fml-owner-share: 100%;\"\u003e\u003c\/i\u003e\u003c\/div\u003e\n\u003cb data-owner-bridge-value\u003e$1.1M\u003c\/b\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-bar-row\" data-owner-bridge=\"grossProfit\"\u003e\n\u003cspan\u003eGross profit\u003c\/span\u003e\u003cdiv\u003e\u003ci style=\"--fml-owner-share: 85%;\"\u003e\u003c\/i\u003e\u003c\/div\u003e\n\u003cb data-owner-bridge-value\u003e$911K\u003c\/b\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-bar-row\" data-owner-bridge=\"operatingCosts\"\u003e\n\u003cspan\u003eOperating costs\u003c\/span\u003e\u003cdiv\u003e\u003ci style=\"--fml-owner-share: 16%;\"\u003e\u003c\/i\u003e\u003c\/div\u003e\n\u003cb data-owner-bridge-value\u003e$176K\u003c\/b\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-bar-row\" data-owner-bridge=\"reserveAmount\"\u003e\n\u003cspan\u003eReserves\u003c\/span\u003e\u003cdiv\u003e\u003ci style=\"--fml-owner-share: 23%;\"\u003e\u003c\/i\u003e\u003c\/div\u003e\n\u003cb data-owner-bridge-value\u003e$250K\u003c\/b\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-bar-row\" data-owner-bridge=\"ownerIncome\"\u003e\n\u003cspan\u003eOwner income\u003c\/span\u003e\u003cdiv\u003e\u003ci style=\"--fml-owner-share: 45%;\"\u003e\u003c\/i\u003e\u003c\/div\u003e\n\u003cb data-owner-bridge-value\u003e$485K\u003c\/b\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"fml-owner-export\" type=\"button\" data-owner-export\u003eEXPORT XLSX\u003c\/button\u003e\u003c\/aside\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-note\"\u003e\n\u003cspan class=\"fml-owner-note-icon\" aria-hidden=\"true\"\u003e!\u003c\/span\u003e\u003cp\u003e\u003cstrong\u003ePlanning note:\u003c\/strong\u003e Research-based planning estimate only. It is not guaranteed salary, tax advice, or owner distribution advice.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003cbr\u003e\u003cdiv class=\"container_new_design_blog\"\u003e\n\n\u003cdiv class=\"text-section_blog text-2_new_design_blog\"\u003e\n\n\u003cdiv class=\"line_top_blog\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\n\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003eHow do you check owner income in the Stem Cell Therapy Clinic model?\u003c\/span\u003e\u003c\/h3\u003e\n\n\u003cp\u003eThis \u003ca href=\"\/products\/stem-cell-therapy-financial-model\"\u003eStem Cell Therapy Clinic Financial Model Template\u003c\/a\u003e shows revenue, margin, costs, reserves, and owner take-home—open the model.\u003c\/p\u003e\n\n\u003ch4\u003eOwner-income model highlights\u003c\/h4\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eMedical Director salary split\u003c\/li\u003e\n\u003cli\u003eRevenue, margin, and cash flow\u003c\/li\u003e\n\u003cli\u003eLow, base, high scenarios\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003c\/div\u003e\n\n\u003cdiv class=\"image-section_blog image-2_new_design_blog\"\u003e\n\n\u003cdiv class=\"preview-card\" data-preview-src=\"\/cdn\/shop\/files\/stem-cell-therapy-financial-model-dashboard-financialmodelslab_cc93c942-4521-434d-858e-67a939b7f1c0.webp\"\u003e\n\u003cimg class=\"preview-img\" width=\"100%\" height=\"auto\" src=\"\/cdn\/shop\/files\/stem-cell-therapy-financial-model-dashboard-financialmodelslab_cc93c942-4521-434d-858e-67a939b7f1c0.webp?width=500\" alt=\"Stem Cell Therapy Clinic Financial Model dashboard summarizing key KPIs, runway and cash position with a dynamic dashboard for clinic performance tracking, investor-ready charts and cash-flow visibility.\"\u003e\n\u003cdiv class=\"preview-overlay\"\u003e\n\u003cbutton class=\"preview-btn\" type=\"button\" style=\"align-items: center; vertical-align: middle; display: inline-flex; justify-content: center; gap: 6px; line-height: 1;\"\u003e\nPREVIEW \u003csvg fill=\"#fff\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" aria-hidden=\"true\" focusable=\"false\" role=\"presentation\" viewbox=\"0 0 448 512\" width=\"14\"\u003e\u003cpath d=\"M416 176V86.63L246.6 256L416 425.4V336c0-8.844 7.156-16 16-16s16 7.156 16 16v128c0 8.844-7.156 16-16 16h-128c-8.844 0-16-7.156-16-16s7.156-16 16-16h89.38L224 278.6L54.63 448H144C152.8 448 160 455.2 160 464S152.8 480 144 480h-128C7.156 480 0 472.8 0 464v-128C0 327.2 7.156 320 16 320S32 327.2 32 336v89.38L201.4 256L32 86.63V176C32 184.8 24.84 192 16 192S0 184.8 0 176v-128C0 39.16 7.156 32 16 32h128C152.8 32 160 39.16 160 48S152.8 64 144 64H54.63L224 233.4L393.4 64H304C295.2 64 288 56.84 288 48S295.2 32 304 32h128C440.8 32 448 39.16 448 48v128C448 184.8 440.8 192 432 192S416 184.8 416 176z\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\n\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eCan a non-physician own a stem cell clinic?\u003c\/span\u003e\u003c\/h2\u003e\u003cbr\u003e\n\u003cp\u003e\u003cstrong\u003eYes, sometimes\u003c\/strong\u003e—but a non-physician can’t assume they can run it freely, because ownership, clinical supervision, scope of practice, licensing, and management rules depend on \u003cstrong\u003estate law\u003c\/strong\u003e and professional review. Here’s the quick math: an \u003cstrong\u003eowner-clinician\u003c\/strong\u003e model may combine operating profit with a \u003cstrong\u003e$320,000 Medical Director salary\u003c\/strong\u003e, but it also ties owner time to patient care. A \u003cstrong\u003emedical director\u003c\/strong\u003e model treats that \u003cstrong\u003e$320,000\u003c\/strong\u003e as a hired clinical leadership cost, while an investor-style model usually takes distributions only after payroll, compliance, reserves, and debt.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-Orange-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eIncome and control\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eOwner-clinician\u003c\/strong\u003e links pay to care.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e$320,000\u003c\/strong\u003e can be salary or profit.\u003c\/li\u003e\n\u003cli\u003eMore control, less time freedom.\u003c\/li\u003e\n\u003cli\u003eState rules shape the structure.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-Orange-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eScale and risk\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eUse physicians and physician assistants.\u003c\/li\u003e\n\u003cli\u003eAdd nurses, medical assistants, front desk.\u003c\/li\u003e\n\u003cli\u003eScale only with compliance and demand.\u003c\/li\u003e\n\u003cli\u003eMore volume needs better documentation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWhat profit margin can a stem cell therapy clinic have?\u003c\/span\u003e\u003c\/h2\u003e\u003cbr\u003e\n\u003cp\u003eA \u003cstrong\u003eStem Cell Therapy Clinic\u003c\/strong\u003e can show very high paper margins in the researched first-year case: \u003cstrong\u003e850%\u003c\/strong\u003e gross margin, \u003cstrong\u003e775%\u003c\/strong\u003e contribution margin, and about \u003cstrong\u003e481%\u003c\/strong\u003e operating margin. If you’re checking clinic economics, \u003ca href=\"\/blogs\/kpi-metrics\/stem-cell-therapy\"\u003eWhat 5 KPIs Matter For Stem Cell Therapy Clinic?\u003c\/a\u003e helps put those numbers in context, but actual owner take-home can fall fast with reserves, debt service, refunds, or expansion spend.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-Orange-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eMargin math\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003e\n\u003cstrong\u003e850%\u003c\/strong\u003e gross margin in year one\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e120%\u003c\/strong\u003e biologic procedure kits\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e30%\u003c\/strong\u003e lab processing contribution\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e775%\u003c\/strong\u003e contribution margin after marketing and supplies\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-Orange-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eFixed cost load\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003e\n\u003cstrong\u003e$27,700\u003c\/strong\u003e monthly fixed overhead\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e$15,000\u003c\/strong\u003e facility lease\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e$4,500\u003c\/strong\u003e malpractice insurance\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e$777,000\u003c\/strong\u003e first-year payroll drag\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eHow much revenue can a stem cell therapy clinic make?\u003c\/span\u003e\u003c\/h2\u003e\u003cbr\u003e\n\u003cp\u003eA \u003cstrong\u003eStem Cell Therapy Clinic\u003c\/strong\u003e can make about \u003cstrong\u003e$314,325 per month\u003c\/strong\u003e, or \u003cstrong\u003e$3.77 million per year\u003c\/strong\u003e, in its first year; a mature clinic model reaches about \u003cstrong\u003e$2.15 million per month\u003c\/strong\u003e, or \u003cstrong\u003e$25.76 million per year\u003c\/strong\u003e. Keep revenue separate from owner income when planning \u003ca href=\"\/blogs\/how-to-open\/stem-cell-therapy\"\u003eHow To Launch A Stem Cell Therapy Clinic?\u003c\/a\u003e because payroll, malpractice, rent, marketing, compliance, debt, and reserves come out first.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-Orange-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eRevenue Build\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003e\n\u003cstrong\u003e225\u003c\/strong\u003e orthopedic treatments at \u003cstrong\u003e$7,000\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e8\u003c\/strong\u003e sports medicine treatments at \u003cstrong\u003e$6,000\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e525\u003c\/strong\u003e spine treatments at \u003cstrong\u003e$8,500\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e96\u003c\/strong\u003e physical therapy visits at \u003cstrong\u003e$200\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-Orange-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eWhat Drives It\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eBook more qualified consultations\u003c\/li\u003e\n\u003cli\u003eImprove consult-to-treatment conversion\u003c\/li\u003e\n\u003cli\u003eProtect collected cash price\u003c\/li\u003e\n\u003cli\u003eMatch demand to provider capacity\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\n\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWant to see what drives owner take-home?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003csection class=\"fml-main-income-drivers\" aria-label=\"Main income drivers for the stem cell therapy clinic.\"\u003e\u003carticle class=\"driver-option is-cards\"\u003e\u003cdiv class=\"main-driver-grid\"\u003e\n\u003carticle class=\"main-driver-card is-primary\"\u003e\u003cdiv class=\"main-driver-heading\"\u003e\n\u003cspan class=\"driver-rank\"\u003e1\u003c\/span\u003e\u003ch4\u003eTreatment Volume\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e$314K\/mo\u003c\/strong\u003e\u003cp\u003eMore consults that convert to procedures push the first-year revenue base higher, so this is the main driver of owner take-home.\u003c\/p\u003e\u003c\/article\u003e\u003carticle class=\"main-driver-card\"\u003e\u003cdiv class=\"main-driver-heading\"\u003e\n\u003cspan class=\"driver-rank\"\u003e2\u003c\/span\u003e\u003ch4\u003ePrice Mix\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e$1.5K-$9.3K\u003c\/strong\u003e\u003cp\u003eA heavier mix of higher-priced procedures lifts collected revenue per case and raises take-home without adding the same number of visits.\u003c\/p\u003e\u003c\/article\u003e\u003carticle class=\"main-driver-card\"\u003e\u003cdiv class=\"main-driver-heading\"\u003e\n\u003cspan class=\"driver-rank\"\u003e3\u003c\/span\u003e\u003ch4\u003eGross Margin\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e85%\u003c\/strong\u003e\u003cp\u003eDirect kit and lab costs decide how much of each dollar stays after procedure inputs, and that flow-through shows up in profit.\u003c\/p\u003e\u003c\/article\u003e\u003carticle class=\"main-driver-card\"\u003e\u003cdiv class=\"main-driver-heading\"\u003e\n\u003cspan class=\"driver-rank\"\u003e4\u003c\/span\u003e\u003ch4\u003eStaffing Cost\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e$64.8K\/mo\u003c\/strong\u003e\u003cp\u003eProvider count and hours drive payroll, so tight scheduling keeps labor from eating the cash left for the owner.\u003c\/p\u003e\u003c\/article\u003e\u003carticle class=\"main-driver-card\"\u003e\u003cdiv class=\"main-driver-heading\"\u003e\n\u003cspan class=\"driver-rank\"\u003e5\u003c\/span\u003e\u003ch4\u003eClinic Overhead\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e$27.7K\/mo\u003c\/strong\u003e\u003cp\u003eLease, insurance, IT, utilities, admin, and compliance costs hit profit every month, and even small creep lowers take-home.\u003c\/p\u003e\u003c\/article\u003e\u003carticle class=\"main-driver-card\"\u003e\u003cdiv class=\"main-driver-heading\"\u003e\n\u003cspan class=\"driver-rank\"\u003e6\u003c\/span\u003e\u003ch4\u003eCash Buffer\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e$756K\u003c\/strong\u003e\u003cp\u003eReserves set how much profit can be paid out as owner distributions without starving working capital during the Month 2 cash dip.\u003c\/p\u003e\u003c\/article\u003e\n\u003c\/div\u003e\u003c\/article\u003e\u003c\/section\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eStem Cell Therapy Clinic Core Six Income Drivers\u003c\/span\u003e\u003c\/h2\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003eTreatment Volume and Conversion\u003c\/span\u003e\u003c\/h3\u003e\u003cbr\u003e\n\u003cdiv class=\"container_new_design_timeline\"\u003e\n  \u003cdiv class=\"left-row1\"\u003e\n    \u003ch3\u003eTreatment Volume and Conversion\u003c\/h3\u003e\n    \u003cp\u003eMore qualified consults and a better consult-to-treatment close rate raise collected revenue and spread fixed costs across more procedures. This model assumes \u003cstrong\u003e16,175\u003c\/strong\u003e blended monthly treatment visits at current capacity, with core volume from \u003cstrong\u003e225\u003c\/strong\u003e regenerative orthopedist, \u003cstrong\u003e8\u003c\/strong\u003e sports medicine, and \u003cstrong\u003e525\u003c\/strong\u003e spine specialist treatments, plus \u003cstrong\u003e30\u003c\/strong\u003e physician assistant treatments and \u003cstrong\u003e96\u003c\/strong\u003e physical therapy visits.\u003c\/p\u003e\n    \u003cp\u003eHere’s the quick math: a \u003cstrong\u003e10%\u003c\/strong\u003e volume lift at the same blended revenue adds about \u003cstrong\u003e$31,433\u003c\/strong\u003e in monthly revenue before costs. The catch is simple: if leads do not book, qualify, or convert, you pay for traffic without getting paid back. This driver only helps owner income when scheduling, provider time, and compliance can absorb the extra demand.\u003c\/p\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"right-row1\"\u003e\n    \u003cdiv class=\"tips-box\"\u003e\n      \u003ch3\u003eTrack Bookings, Show Rate, and Close Rate\u003c\/h3\u003e\n      \u003cp\u003eMeasure the funnel from lead to booked consult to treatment, not just total leads. If the clinic is filling volume, watch whether consult slots, physician time, and follow-up capacity keep pace; otherwise, conversion drops and revenue gets stuck below capacity. A tighter schedule with more qualified patients can push operating leverage up fast.\u003c\/p\u003e\n      \u003cp\u003eUse one weekly view with \u003cstrong\u003ebooked consults\u003c\/strong\u003e, \u003cstrong\u003eshow rate\u003c\/strong\u003e, \u003cstrong\u003econsult-to-treatment conversion\u003c\/strong\u003e, and \u003cstrong\u003emonthly treatment visits\u003c\/strong\u003e. If demand rises but the treatment team cannot handle it, the extra spend turns into wasted acquisition cost, slower cash collection, and less take-home profit for the owner.\u003c\/p\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"timeline\"\u003e\u003c\/div\u003e\n  \u003cdiv class=\"step-circle step1\"\u003e1\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003eAverage Collected Treatment Price and Service Mix\u003c\/span\u003e\u003c\/h3\u003e\u003cbr\u003e\n\u003cdiv class=\"container_new_design_timeline\"\u003e\n  \u003cdiv class=\"right-row2\"\u003e\n    \u003ch3\u003eAverage Collected Treatment Price and Service Mix\u003c\/h3\u003e\n    \u003cp\u003eIf the clinic shifts toward higher-priced physician-led cases, owner income rises fast. First-year prices range from \u003cstrong\u003e$8,500\u003c\/strong\u003e for spine specialist treatments to \u003cstrong\u003e$200\u003c\/strong\u003e for physical therapy visits, and the blended first-year average is about \u003cstrong\u003e$1,943\u003c\/strong\u003e per treatment visit because lower-priced support care pulls the mix down.\u003c\/p\u003e\n    \u003cp\u003eHere’s the quick math: more spine and regenerative orthopedist volume lifts collected revenue, while more physician assistant and therapy visits lower it. The average is not fixed nationally; it moves with local affordability, positioning, compliance, and \u003cstrong\u003ecollection rates\u003c\/strong\u003e (cash actually collected). Price too high and demand can soften; price too low and owner pay shrinks.\u003c\/p\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"left-row2\"\u003e\n    \u003cdiv class=\"tips-box\"\u003e\n      \u003ch3\u003eMix and Price Controls\u003c\/h3\u003e\n      \u003cp\u003eTrack each service line’s \u003cstrong\u003ecollected price\u003c\/strong\u003e, not just list price: regenerative orthopedist \u003cstrong\u003e$7,000\u003c\/strong\u003e, sports medicine \u003cstrong\u003e$6,000\u003c\/strong\u003e, spine specialist \u003cstrong\u003e$8,500\u003c\/strong\u003e, physician assistant \u003cstrong\u003e$1,500\u003c\/strong\u003e, and physical therapy \u003cstrong\u003e$200\u003c\/strong\u003e. Watch mix by visit type, consult-to-treatment conversion, and cash collection lag so the forecast reflects what actually lands in the bank.\u003c\/p\u003e\n      \u003cp\u003eUse bundled plans, consultation fees, and follow-up pricing to raise realized revenue, but keep affordability and compliance tight. If lower-priced support visits grow faster than physician-led cases, blended revenue drops and fixed costs eat more of each dollar, which can cut the owner’s draw even when visit count looks healthy.\u003c\/p\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"timeline\"\u003e\u003c\/div\u003e\n  \u003cdiv class=\"step-circle step2\"\u003e2\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003eGross Margin and Direct Treatment Costs\u003c\/span\u003e\u003c\/h3\u003e\u003cbr\u003e\n\u003cdiv class=\"container_new_design_timeline\"\u003e\n  \u003cdiv class=\"left-row3\"\u003e\n    \u003ch3\u003eDirect Cost Control\u003c\/h3\u003e\n    \u003cp\u003eGross margin is what stays after direct treatment costs. In this model, first-year direct COGS are \u003cstrong\u003e120%\u003c\/strong\u003e for biologic procedure kits and \u003cstrong\u003e30%\u003c\/strong\u003e for laboratory processing fees, and the plan states that creates an \u003cstrong\u003e850%\u003c\/strong\u003e gross margin. On \u003cstrong\u003e$314,325\u003c\/strong\u003e of monthly revenue, each \u003cstrong\u003e1 point\u003c\/strong\u003e of margin is about \u003cstrong\u003e$3,143\u003c\/strong\u003e a month before overhead.\u003c\/p\u003e\n    \u003cp\u003eMature-year assumptions improve to \u003cstrong\u003e100%\u003c\/strong\u003e kits and \u003cstrong\u003e22%\u003c\/strong\u003e lab fees, which the model states lifts gross margin to \u003cstrong\u003e878%\u003c\/strong\u003e. Margin only helps owner pay if care quality, safety steps, and documentation stay intact. Vendor cost creep, rework, refunds, and missing records can erase take-home fast.\u003c\/p\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"right-row3\"\u003e\n    \u003cdiv class=\"tips-box\"\u003e\n      \u003ch3\u003eProtect Gross Margin\u003c\/h3\u003e\n      \u003cp\u003eTrack direct cost per case, not just total spend. The key inputs are treatment volume, kit cost, lab fee, refund rate, and rework rate. If any of those drift, gross margin drops before fixed overhead ever shows up.\u003c\/p\u003e\n      \u003cul class=\"lst_crct_blog\"\u003e\n        \u003cli\u003eReview kit cost monthly\u003c\/li\u003e\n        \u003cli\u003eAudit lab fees per procedure\u003c\/li\u003e\n        \u003cli\u003eFlag rework and refunds\u003c\/li\u003e\n        \u003cli\u003eLock vendor price changes\u003c\/li\u003e\n      \u003c\/ul\u003e\n      \u003cp\u003eUse monthly variance checks to compare actual direct COGS against plan. If costs rise but pricing stays flat, each procedure funds less owner income. Direct-cost targets should be planning inputs, not a reason to weaken compliance or skip documentation.\u003c\/p\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"timeline\"\u003e\u003c\/div\u003e\n  \u003cdiv class=\"step-circle step3\"\u003e3\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003eProvider Capacity and Staffing Costs\u003c\/span\u003e\u003c\/h3\u003e\u003cbr\u003e\n\u003cdiv class=\"container_new_design_timeline\"\u003e\n\u003cdiv class=\"right-row4\"\u003e\n\u003ch3\u003eProvider Capacity and Staffing Costs\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eProvider time creates revenue, but payroll hits first.\u003c\/strong\u003e First-year staffing is budgeted at \u003cstrong\u003e$777,000\u003c\/strong\u003e annually, or \u003cstrong\u003e$64,750\u003c\/strong\u003e a month. That fixed load only works if visit volume fills the clinical schedule: capacity assumptions are \u003cstrong\u003e450%\u003c\/strong\u003e for regenerative orthopedists, \u003cstrong\u003e400%\u003c\/strong\u003e for sports medicine physicians, \u003cstrong\u003e350%\u003c\/strong\u003e for spine specialists, \u003cstrong\u003e500%\u003c\/strong\u003e for physician assistants, and \u003cstrong\u003e600%\u003c\/strong\u003e for physical therapists. If demand lags, owner pay gets squeezed fast.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHere’s the quick math:\u003c\/strong\u003e at about \u003cstrong\u003e$314,325\u003c\/strong\u003e monthly revenue, payroll is roughly \u003cstrong\u003e20.6%\u003c\/strong\u003e of sales before rent, malpractice, and other overhead. The mix matters too: a \u003cstrong\u003e$320,000\u003c\/strong\u003e medical director, \u003cstrong\u003e$95,000\u003c\/strong\u003e clinic manager, \u003cstrong\u003e$170,000\u003c\/strong\u003e in registered nurses, and \u003cstrong\u003e$90,000\u003c\/strong\u003e in medical assistants must match scope of practice and state rules. Hire too early and cash burns; hire too late and capacity gets blocked.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"left-row4\"\u003e\n\u003cdiv class=\"tips-box\"\u003e\n\u003ch3\u003eStaff to Demand, Not Hope\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eTrack booked treatments per provider, not headcount alone.\u003c\/strong\u003e Build schedules from expected consults, treatment mix, supervision limits, and no-show rates. The goal is simple: keep provider time productive enough to absorb the fixed payroll burden. If a role cannot show a clear path to filled clinical time, it should wait. One clean rule: add people only when booked volume is visible.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eBooked visits by provider type\u003c\/li\u003e\n\u003cli\u003ePayroll as a sales percent\u003c\/li\u003e\n\u003cli\u003eUtilization, or filled clinical time\u003c\/li\u003e\n\u003cli\u003eOpen slots versus waitlist\u003c\/li\u003e\n\u003cli\u003eScope and supervision limits\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWhat this estimate hides:\u003c\/strong\u003e staffing can look fine on paper and still miss cash if onboarding runs long, schedules are uneven, or state rules force extra supervision. The owner’s take-home income improves when each added hire raises filled capacity faster than payroll rises; if not, profit and distributions stall.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003eOverhead, Malpractice, and Compliance Costs\u003c\/span\u003e\u003c\/h3\u003e\u003cbr\u003e\n\u003cdiv class=\"container_new_design_timeline\"\u003e\n\u003cdiv class=\"left-row5\"\u003e\n\u003ch3\u003eFixed Overhead, Malpractice, and Compliance Costs\u003c\/h3\u003e\n\u003cp\u003eWhen a stem cell clinic is ramping up, \u003cstrong\u003efixed overhead\u003c\/strong\u003e comes out before owner pay and can squeeze profit fast. The first-year monthly load is \u003cstrong\u003e$27,700\u003c\/strong\u003e, or \u003cstrong\u003e$332,400\u003c\/strong\u003e a year, and it is mostly due even when procedure volum\ne is soft. That makes cash flow tight early on, so the owner’s take-home depends on how quickly visits cover rent, insurance, systems, and compliance spend.\u003c\/p\u003e\n\u003cp\u003eHere’s the quick math: \u003cstrong\u003e$15,000\u003c\/strong\u003e lease, \u003cstrong\u003e$4,500\u003c\/strong\u003e malpractice insurance, \u003cstrong\u003e$2,200\u003c\/strong\u003e EHR and IT, \u003cstrong\u003e$3,000\u003c\/strong\u003e utilities and maintenance, \u003cstrong\u003e$1,200\u003c\/strong\u003e admin office costs, and \u003cstrong\u003e$1,800\u003c\/strong\u003e compliance and accreditation. The key inputs are monthly volume, collected revenue per treatment, and whether documentation, legal review, quality systems, and insurance stay in budget. \u003cstrong\u003eLow volume plus fixed overhead means margin pressure.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"right-row5\"\u003e\n\u003cdiv class=\"tips-box\"\u003e\n\u003ch3\u003eTrack the Fixed Cost Run Rate\u003c\/h3\u003e\n\u003cp\u003eMeasure overhead as a \u003cstrong\u003emonthly run rate\u003c\/strong\u003e, not a yearly guess. If the clinic misses one line item, the owner feels it in lower operating profit and a smaller draw. Track lease, malpractice, software, utilities, office spend, and compliance work separately, then compare them to monthly treatment volume and collected revenue. That shows whether growth is really covering fixed costs or just keeping the lights on.\u003c\/p\u003e\n\u003cp\u003eUse a simple control rule: if soft months are common, keep a reserve for \u003cstrong\u003edocumentation, legal review, quality systems, and insurance\u003c\/strong\u003e. Those costs can rise without warning, and underbudgeting them can hit cash before revenue catches up. One clean check helps: \u003cstrong\u003efixed overhead ÷ monthly collected revenue\u003c\/strong\u003e. If that ratio stays high, the clinic needs more volume or tighter cost control before owner pay improves.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"timeline\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"step-circle step5\"\u003e5\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003eCash Reserves, Debt Service, and Distributions\u003c\/span\u003e\u003c\/h3\u003e\u003cbr\u003e\n\u003cdiv class=\"container_new_design_timeline\"\u003e\n  \u003cdiv class=\"right-row6\"\u003e\n    \u003ch3\u003eCash Before Owner Draws\u003c\/h3\u003e\n    \u003cp\u003e\u003cstrong\u003eOperating profit\u003c\/strong\u003e is not the same as cash you can take home. Here, first-year operating profit is about \u003cstrong\u003e$151,152 per month\u003c\/strong\u003e before taxes, debt service, and reserves, so actual distributions can be much lower during ramp-up.\u003c\/p\u003e\n    \u003cp\u003eThe cash need is real because planned capital spending totals \u003cstrong\u003e$350,000\u003c\/strong\u003e: \u003cstrong\u003e$85,000\u003c\/strong\u003e for centrifuge systems, \u003cstrong\u003e$120,000\u003c\/strong\u003e for imaging, \u003cstrong\u003e$65,000\u003c\/strong\u003e for procedure room buildout, \u003cstrong\u003e$45,000\u003c\/strong\u003e for EHR implementation, and \u003cstrong\u003e$35,000\u003c\/strong\u003e for lab equipment. If that spend is financed, debt service cuts owner pay; if paid in cash, launch liquidity drops.\u003c\/p\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"left-row6\"\u003e\n    \u003cdiv class=\"tips-box\"\u003e\n      \u003ch3\u003eTrack Cash After Debt\u003c\/h3\u003e\n      \u003cp\u003eMeasure \u003cstrong\u003emonthly cash after debt service and reserve funding\u003c\/strong\u003e, not just EBITDA. Good inputs are profit, loan payment, tax set-asides, and the cash kept for marketing, working capital, refunds, compliance review, and expansion spending.\u003c\/p\u003e\n      \u003cul class=\"lst_crct_blog\"\u003e\n        \u003cli\u003eSet a minimum cash reserve.\u003c\/li\u003e\n        \u003cli\u003eModel financed versus cash buy.\u003c\/li\u003e\n        \u003cli\u003eReview distributions every month.\u003c\/li\u003e\n      \u003c\/ul\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"timeline\"\u003e\u003c\/div\u003e\n  \u003cdiv class=\"step-circle step6\"\u003e6\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eCompare low, base, and high owner income scenarios\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003csection class=\"fml-scenario-table\" aria-label=\"Stem Cell Therapy Clinic Owner Income Scenarios\" data-site-name=\"Financial Models Lab\" data-site-url=\"https:\/\/financialmodelslab.com\" data-source-title=\"Stem Cell Therapy Clinic Owner Income Scenarios\" data-note-label=\"Planning note\" data-note-text=\"These scenario ranges are researched planning assumptions, not guaranteed earnings, salary promises, tax advice, or distributions.\"\u003e\u003cdiv class=\"fml-scenario-table-card\"\u003e\n\u003cheader class=\"fml-scenario-table-header\"\u003e\u003cdiv\u003e\n\u003cp class=\"fml-scenario-table-eyebrow\"\u003eOwner income scenarios\u003c\/p\u003e\n\u003cp class=\"fml-scenario-table-description\"\u003eOwner income moves with case mix, capacity, staffing, and patient acquisition. The low, base, and high cases show how fast a launch can turn into cash or just cover overhead.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-scenario-table-actions\"\u003e\u003cbutton class=\"fml-scenario-table-export\" type=\"button\" data-scenario-export\u003eEXPORT XLSX\u003c\/button\u003e\u003c\/div\u003e\u003c\/header\u003e\u003cdiv class=\"fml-scenario-table-wrap\"\u003e\u003ctable class=\"fml-scenario-table-grid\"\u003e\n\u003ccaption\u003eA quick view of owner income at slow launch, modeled launch, and scaled operation.\u003c\/caption\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth class=\"fml-scenario-table-stub\" scope=\"col\" data-export-value=\"Scenario\"\u003eScenario\u003c\/th\u003e\n\u003cth class=\"fml-scenario-table-column\" scope=\"col\" data-export-value=\"Low Case\"\u003e\n\u003cspan class=\"fml-scenario-column-title\"\u003eLow Case\u003c\/span\u003e\u003cspan class=\"fml-scenario-badge is-soft\"\u003eRamp-up risk\u003c\/span\u003e\n\u003c\/th\u003e\n\u003cth class=\"fml-scenario-table-column\" scope=\"col\" data-export-value=\"Base Case\"\u003e\n\u003cspan class=\"fml-scenario-column-title\"\u003eBase Case\u003c\/span\u003e\u003cspan class=\"fml-scenario-badge is-soft\"\u003eBase plan\u003c\/span\u003e\n\u003c\/th\u003e\n\u003cth class=\"fml-scenario-table-column\" scope=\"col\" data-export-value=\"High Case\"\u003e\n\u003cspan class=\"fml-scenario-column-title\"\u003eHigh Case\u003c\/span\u003e\u003cspan class=\"fml-scenario-badge is-warning\"\u003eScaled clinic\u003c\/span\u003e\n\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr data-scenario-row\u003e\n\u003cth class=\"fml-scenario-row-heading\" scope=\"row\" data-export-value=\"Launch model\"\u003e\u003cspan class=\"fml-scenario-row-heading-inner\"\u003e\u003cspan class=\"fml-scenario-row-icon is-launch\" aria-hidden=\"true\"\u003e\u003cimg class=\"fml-scenario-row-icon-img\" src=\"\/cdn\/shop\/files\/scenario-launch-model.svg\" alt=\"Launch model icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003e\u003cspan class=\"fml-scenario-row-title\"\u003eLaunch model\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/th\u003e\n\u003ctd data-export-value=\"A slower launch with lower capacity and weaker conversion keeps owner income tight.\"\u003eA slower launch with lower capacity and weaker conversion keeps owner income tight.\u003c\/td\u003e\n\u003ctd data-export-value=\"The modeled launch supports steady owner income once first-year volume and pricing hold.\"\u003eThe modeled launch supports steady owner income once first-year volume and pricing hold.\u003c\/td\u003e\n\u003ctd data-export-value=\"A stronger ramp with mature-year volume and a richer service mix lifts owner income sharply.\"\u003eA stronger ramp with mature-year volume and a richer service mix lifts owner income sharply.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-scenario-row\u003e\n\u003cth class=\"fml-scenario-row-heading\" scope=\"row\" data-export-value=\"Typical setup\"\u003e\u003cspan class=\"fml-scenario-row-heading-inner\"\u003e\u003cspan class=\"fml-scenario-row-icon is-setup\" aria-hidden=\"true\"\u003e\u003cimg class=\"fml-scenario-row-icon-img\" src=\"\/cdn\/shop\/files\/scenario-typical-setup.svg\" alt=\"Typical setup icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003e\u003cspan class=\"fml-scenario-row-title\"\u003eTypical setup\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/th\u003e\n\u003ctd data-export-value=\"Revenue runs below the first-year modeled $314,325 monthly level, while fixed overhead stays at $27,700 and payroll still starts around $64,750.\"\u003eRevenue runs below the first-year modeled $314,325 monthly level, while fixed overhead stays at $27,700 and payroll still starts around $64,750.\u003c\/td\u003e\n\u003ctd data-export-value=\"The clinic runs at the first-year plan with $314,325 monthly revenue, 85.0% gross margin, 77.5% contribution margin, $64,750 monthly payroll, $27,700 fixed overhead, and about $151,152 monthly operating profit before taxes, debt, and reserves.\"\u003eThe clinic runs at the first-year plan with $314,325 monthly revenue, 85.0% gross margin, 77.5% contribution margin, $64,750 monthly payroll, $27,700 fixed overhead, and about $151,152 monthly operating profit before taxes, debt, and reserves.\u003c\/td\u003e\n\u003ctd data-export-value=\"The clinic reaches mature-year scale at about $2.15M monthly revenue, 87.8% gross margin, and about $1.62M monthly operating profit before taxes, debt, and reserves.\"\u003eThe clinic reaches mature-year scale at about $2.15M monthly revenue, 87.8% gross margin, and about $1.62M monthly operating profit before taxes, debt, and reserves.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-scenario-row\u003e\n\u003cth class=\"fml-scenario-row-heading\" scope=\"row\" data-export-value=\"Cost drivers\"\u003e\u003cspan class=\"fml-scenario-row-heading-inner\"\u003e\u003cspan class=\"fml-scenario-row-icon is-drivers\" aria-hidden=\"true\"\u003e\u003cimg class=\"fml-scenario-row-icon-img\" src=\"\/cdn\/shop\/files\/scenario-cost-drivers.svg\" alt=\"Cost drivers icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003e\u003cspan class=\"fml-scenario-row-title\"\u003eCost drivers\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/th\u003e\n\u003ctd data-export-value=\"lower case volume; weaker conversion; same lease and insurance; full launch payroll; patient acquisition spend\"\u003e\u003cul class=\"fml-scenario-list\"\u003e\n\u003cli\u003elower case volume\u003c\/li\u003e\n\u003cli\u003eweaker conversion\u003c\/li\u003e\n\u003cli\u003esame lease and insurance\u003c\/li\u003e\n\u003cli\u003efull launch payroll\u003c\/li\u003e\n\u003cli\u003epatient acquisition spend\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/td\u003e\n\u003ctd data-export-value=\"first-year revenue; 85.0% gross margin; 77.5% contribution margin; $64,750 payroll; $27,700 fixed overhead\"\u003e\u003cul class=\"fml-scenario-list\"\u003e\n\u003cli\u003efirst-year revenue\u003c\/li\u003e\n\u003cli\u003e85.0% gross margin\u003c\/li\u003e\n\u003cli\u003e77.5% contribution margin\u003c\/li\u003e\n\u003cli\u003e$64,750 payroll\u003c\/li\u003e\n\u003cli\u003e$27,700 fixed overhead\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/td\u003e\n\u003ctd data-export-value=\"mature case volume; stronger conversion; 87.8% gross margin; larger staffing load; steady fixed overhead\"\u003e\u003cul class=\"fml-scenario-list\"\u003e\n\u003cli\u003emature case volume\u003c\/li\u003e\n\u003cli\u003estronger conversion\u003c\/li\u003e\n\u003cli\u003e87.8% gross margin\u003c\/li\u003e\n\u003cli\u003elarger staffing load\u003c\/li\u003e\n\u003cli\u003esteady fixed overhead\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-scenario-row\u003e\n\u003cth class=\"fml-scenario-row-heading\" scope=\"row\" data-export-value=\"Owner income range\"\u003e\u003cspan class=\"fml-scenario-row-heading-inner\"\u003e\u003cspan class=\"fml-scenario-row-icon is-range\" aria-hidden=\"true\"\u003e\u003cimg class=\"fml-scenario-row-icon-img\" src=\"\/cdn\/shop\/files\/scenario-planning-range.svg\" alt=\"Owner income range icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003e\u003cspan class=\"fml-scenario-row-title\"\u003eOwner income range\u003c\/span\u003e\u003cspan class=\"fml-scenario-row-subtitle\"\u003eBefore owner reserves\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/th\u003e\n\u003ctd data-export-value=\"$0 - $50k\/mo\"\u003e\n\u003cstrong class=\"fml-scenario-range\"\u003e$0 - $50k\/mo\u003c\/strong\u003e\u003cspan class=\"fml-scenario-badge is-soft\"\u003eSlow ramp\u003c\/span\u003e\n\u003c\/td\u003e\n\u003ctd data-export-value=\"$151k\/mo\"\u003e\n\u003cstrong class=\"fml-scenario-range\"\u003e$151k\/mo\u003c\/strong\u003e\u003cspan class=\"fml-scenario-badge is-soft\"\u003ePlan case\u003c\/span\u003e\n\u003c\/td\u003e\n\u003ctd data-export-value=\"$1.5M - $1.7M\/mo\"\u003e\n\u003cstrong class=\"fml-scenario-range\"\u003e$1.5M - $1.7M\/mo\u003c\/strong\u003e\u003cspan class=\"fml-scenario-badge is-warning\"\u003eScale case\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-scenario-row\u003e\n\u003cth class=\"fml-scenario-row-heading\" scope=\"row\" data-export-value=\"Best fit\"\u003e\u003cspan class=\"fml-scenario-row-heading-inner\"\u003e\u003cspan class=\"fml-scenario-row-icon is-fit\" aria-hidden=\"true\"\u003e\u003cimg class=\"fml-scenario-row-icon-img\" src=\"\/cdn\/shop\/files\/scenario-best-fit.svg\" alt=\"Best fit icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003e\u003cspan class=\"fml-scenario-row-title\"\u003eBest fit\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/th\u003e\n\u003ctd data-export-value=\"Use this to stress-test cash needs if patient flow is slow and staffing comes on before demand.\"\u003eUse this to stress-test cash needs if patient flow is slow and staffing comes on before demand.\u003c\/td\u003e\n\u003ctd data-export-value=\"Use this as the core operating case for budgeting, hiring, and owner draw planning.\"\u003eUse this as the core operating case for budgeting, hiring, and owner draw planning.\u003c\/td\u003e\n\u003ctd data-export-value=\"Use this to test upside if the clinic scales well and the team can handle higher scheduling, compliance, and acquisition demand.\"\u003eUse this to test upside if the clinic scales well and the team can handle higher scheduling, compliance, and acquisition demand.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\u003c\/div\u003e\n\u003cdiv class=\"fml-scenario-table-note\"\u003e\n\u003cspan class=\"fml-scenario-table-note-icon\" aria-hidden=\"true\"\u003e!\u003c\/span\u003e\u003cp\u003e\u003cstrong\u003ePlanning note:\u003c\/strong\u003e These scenario ranges are researched planning assumptions, not guaranteed earnings, salary promises, tax advice, or distributions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e","brand":"FinancialModelsLab","offers":[{"title":"Default Title","offer_id":49304260018419,"sku":"stem-cell-therapy-owner-makes","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0522\/6191\/2762\/files\/stem-cell-therapy-owner-makes.webp?v=1782693112","url":"https:\/\/financialmodelslab.com\/products\/stem-cell-therapy-owner-makes","provider":"Financial Models Lab","version":"1.0","type":"link"}